Comprehensive non-invasive prenatal screening for pregnancies with elevated risks of genetic disorders: protocol for a prospective, multicentre study
- PMID: 34452972
- PMCID: PMC8404451
- DOI: 10.1136/bmjopen-2021-053617
Comprehensive non-invasive prenatal screening for pregnancies with elevated risks of genetic disorders: protocol for a prospective, multicentre study
Abstract
Introduction: Chromosomal abnormalities and monogenic disorders account for ~15%-25% of recognisable birth defects. With limited treatment options, preconception and prenatal screening were developed to reduce the incidence of such disorders. Currently, non-invasive prenatal screening (NIPS) for common aneuploidies is implemented worldwide with superiority over conventional serum or sonographic screening approaches. However, the clinical validity for the screening of frequent chromosome segmental copy number variations and monogenic disorders still awaits to be proved.
Methods and analysis: This study is a multicentre, prospective study. The participants were recruited from three tertiary hospitals in China starting from 10 April 2021. The study is expected to conclude before 10 October 2022. Pregnant women with abnormal prenatal screening results indicated for invasive prenatal diagnosis or those who decide to terminate their pregnancies due to abnormal ultrasound findings will be evaluated for enrolment. Cell-free DNA extracted from the maternal plasma will be used for an analytically validated comprehensive NIPS test developed by Beijing BioBiggen Technology Co. (Beijing, China). The diagnostic results from prenatal or postnatal specimens as well as the pregnancy outcome data will be collected to examine the clinical sensitivity, specificity, positive and negative predictive values of the test.
Ethics and dissemination: This study was approved by the Obstetrics and Gynecology Hospital of Fudan University (2020-178). Results of this study will be disseminated to public through scientific conferences and a peer-reviewed journal. Written informed consents will be obtained from participants.
Trial registration number: ChiCTR2100045739.
Keywords: antenatal; preventive medicine; reproductive medicine.
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: XC, JZ are employees or shareholders of Beijing BioBiggen Technology Co. The other authors declare no conflict of interest.
Figures


Similar articles
-
Prenatal screening for fetal aneuploidy in singleton pregnancies.J Obstet Gynaecol Can. 2011 Jul;33(7):736-750. doi: 10.1016/S1701-2163(16)34961-1. J Obstet Gynaecol Can. 2011. PMID: 21749752
-
Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.J Obstet Gynaecol Can. 2011 Jul;33(7):754-67. J Obstet Gynaecol Can. 2011. PMID: 21749753
-
[Analysis of non-invasive prenatal screening detection in fetal chromosome aneuploidy].Zhonghua Fu Chan Ke Za Zhi. 2017 Nov 25;52(11):765-769. doi: 10.3760/cma.j.issn.0529-567X.2017.11.009. Zhonghua Fu Chan Ke Za Zhi. 2017. PMID: 29179272 Chinese.
-
Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies.J Obstet Gynaecol Can. 2011 Sep;33(9):955-960. doi: 10.1016/S1701-2163(16)35022-8. J Obstet Gynaecol Can. 2011. PMID: 21923994 Review.
-
Obstetrical complications associated with abnormal maternal serum markers analytes.J Obstet Gynaecol Can. 2008 Oct;30(10):918-932. doi: 10.1016/S1701-2163(16)32973-5. J Obstet Gynaecol Can. 2008. PMID: 19038077 Review. English, French.
Cited by
-
Performance evaluation of noninvasive prenatal testing on 24 chromosomes in a cohort of 118,969 pregnant women in Sichuan, China.J Int Med Res. 2024 Sep;52(9):3000605241274584. doi: 10.1177/03000605241274584. J Int Med Res. 2024. PMID: 39283023 Free PMC article.
-
Comprehensive chromosomal abnormality detection: integrating CNV-Seq with traditional karyotyping in prenatal diagnostics.BMC Med Genomics. 2025 Apr 29;18(1):81. doi: 10.1186/s12920-025-02139-y. BMC Med Genomics. 2025. PMID: 40301840 Free PMC article.
-
Prospective prenatal cell-free DNA screening for genetic conditions of heterogenous etiologies.Nat Med. 2024 Feb;30(2):470-479. doi: 10.1038/s41591-023-02774-x. Epub 2024 Jan 22. Nat Med. 2024. PMID: 38253798
-
Integrating NIPT and ultrasound for detecting fetal aneuploidies and abnormalities.J Perinat Med. 2025 May 28. doi: 10.1515/jpm-2025-0005. Online ahead of print. J Perinat Med. 2025. PMID: 40441708 Review.
References
-
- Brent RL. Environmental causes of human congenital malformations: the pediatrician’s role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors. Pediatrics 2004;113:957–68. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous